Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia

https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30416-X/fulltext

Marked differences exist between antipsychotics in terms of metabolic side-effects, with olanzapine and clozapine exhibiting the worst profiles and aripiprazole, brexpiprazole, cariprazine, lurasidone, and ziprasidone the most benign profiles.